Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

SUPNSUPN
Showing 8 of 22 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in SUPERNUS PHARMACEUTICALS

Qube Research & Technologies Ltd holds 922,166 shares of SUPN (SUPERNUS PHARMACEUTICALS), worth $42.9M as of 2026-Q2. The position was increased (+85.1% shares). SUPN represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$42.9M

Current Shares

922,166

Total Value Change

+$39.7M

Total Shares Change

+821,202

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
922,166
+85.1%
$42.9M0.0%$46.51
45
2026-Q1
Increased
498,198
+59.8%
$25.8M0.0%$54.56
41
2025-Q4
Increased
311,838
+151.2%
$15.5M0.0%$49.89
45
2025-Q3
Decreased
124,123
-46.0%
$5.9M0.0%$47.60
0
2025-Q2
Increased
229,710
+134.2%
$7.2M0.0%$31.16
44
2025-Q1
Increased
98,078
+50.6%
$3.2M0.0%$32.29
37
2024-Q4
Decreased
65,110
-35.5%
$2.4M0.0%$36.91
0
2024-Q3
Decreased
100,964
-37.0%
$3.1M0.0%$30.75
0

Other major holders of SUPN: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used